Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels |
---|---|---|---|---|
1 | ||||
Coagulopathy | Coagulopathy | postmarketing | x | |
Thrombocytopenia | Thrombocytopenia | postmarketing | x | |
Prothrombin level increased | Prothrombin level increased | postmarketing | x | |
Renal failure acute | Shutdown renal | postmarketing | x | |
Activated partial thromboplastin time prolonged | Activated partial thromboplastin time prolonged | postmarketing | x | |
Serum ferritin increased | Serum ferritin increased | postmarketing | x | |
Iron overload | Iron overload | postmarketing | x | |
Body temperature increased | Body temperature increased | x | ||
Leukocytosis | Leukocytosis | x | ||
Phlebitis | Phlebitis | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |